Cisplatin-lnduced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensity
Open Access
- 1 January 1992
- Vol. 69 (1) , 203-207
- https://doi.org/10.1002/1097-0142(19920101)69:1<203::aid-cncr2820690133>3.0.co;2-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Tissue platinum concentrations and cisplatin schedulesThe Lancet, 1990
- Prospective study of nerve conduction parameters and serum magnesium following cisplatin therapyGynecologic Oncology, 1990
- Cisplatin NeurotoxicityNew England Journal of Medicine, 1990
- Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian CancerNew England Journal of Medicine, 1990
- Hypothyroidism and polyneuropathy.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721Cancer, 1988
- Prospective nerve conduction studies in cisplatin therapyAnnals of Neurology, 1988
- Electrophysiological study of the peripheral and central neurotoxic effect of cis-platinActa Neurologica Scandinavica, 1987
- Human diabetic endoneurial sorbitol, fructose, and myo‐inositol related to sural nerve morphometryAnnals of Neurology, 1980
- Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatmentCancer, 1979